RAF1 mutation leading to hypertrophic cardiomyopathy in a Chinese family with a history of sudden cardiac death: A diagnostic insight into Noonan syndrome

被引:1
|
作者
Zheng, Jingjing [1 ,2 ]
Peng, Longyun [3 ]
Cheng, Ruofei [1 ,2 ]
Li, Zhiyan [1 ,2 ]
Xie, Jianjie [1 ,2 ]
Huang, Erwen [1 ,2 ]
Cheng, Jianding [1 ,2 ]
Zhao, Qianhao [1 ,2 ]
机构
[1] Sun Yat Sen Univ, Fac Forens Med, Zhongshan Sch Med, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Guangdong Prov Translat Forens Med Engn Technol Re, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China
来源
MOLECULAR GENETICS & GENOMIC MEDICINE | 2024年 / 12卷 / 01期
基金
中国国家自然科学基金;
关键词
hypertrophic cardiomyopathy; Noonan syndrome; RAF1; gene; RAS-HCM; whole-exome sequencing; OF-FUNCTION MUTATIONS; RARE VARIANTS; PHENOTYPE; SPECTRUM; OUTCOMES;
D O I
10.1002/mgg3.2290
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Hypertrophic cardiomyopathy (HCM) is predominantly caused by mutations in sarcomeric genes. However, a subset of cases is attributed to genetic disorders unrelated to sarcomeric genes, such as Noonan syndrome (NS) and other RASopathies. In this study, we present a family with a history of sudden cardiac death (SCD) and focus on two adults with syndromic left ventricular hypertrophy (LVH).Methods; Clinical evaluations, including echocardiography, were conducted to assess cardiac manifestations. Whole-exome sequencing was performed to identify potential genetic variants underlying syndromic LVH in the study participants.Results: Whole-exome sequencing revealed a missense variant in the RAF1 gene, c.782C>T (p.Pro261Leu). This variant confirmed the diagnosis of NS in the affected individuals.Conclusion: The findings of this study underscore the importance of family history investigation and genetic testing in diagnosing syndromic LVH. By identifying the underlying genetic cause, clinicians can better understand the etiology of RAS-HCM and its association with SCD in young adults.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Co-occurrence of hypertrophic cardiomyopathy and juvenile myelomonocytic leukemia in a neonate with Noonan syndrome, leading to premature death
    Tamura, Akihiro
    Uemura, Suguru
    Matsubara, Kousaku
    Kozuki, Eru
    Tanaka, Toshikatsu
    Nino, Nanako
    Yokoi, Takehito
    Saito, Atsuro
    Ishida, Toshiaki
    Hasegawa, Daiichiro
    Umeki, Ikumi
    Niihori, Tetsuya
    Nakazawa, Yozo
    Koike, Kenichi
    Aoki, Yoko
    Kosaka, Yoshiyuki
    CLINICAL CASE REPORTS, 2018, 6 (07): : 1202 - 1207
  • [32] Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers
    J. T. Vehmeijer
    I. Christiaans
    I. M. van Langen
    E. Birnie
    G. J. Bonsel
    E. M. A. Smets
    A. A. M. Wilde
    Netherlands Heart Journal, 2009, 17 : 464 - 469
  • [33] Sudden cardiac death in familial hypertrophic cardiomyopathy is associated with a novel mutation in the troponin I gene
    Mogensen, J
    Klausen, IC
    Egeblad, H
    Baandrup, U
    CIRCULATION, 1999, 100 (18) : 618 - 618
  • [34] Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers
    Michels, Michelle
    Soliman, Osama I. I.
    Phefferkorn, Judith
    Hoedemaekers, Yvonne M.
    Kofflard, Marcel J.
    Dooijes, Dennis
    Majoor-Krakauer, Danielle
    Ten Cate, Folkert J.
    EUROPEAN HEART JOURNAL, 2009, 30 (21) : 2593 - 2598
  • [35] Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers
    Vehmeijer, J. T.
    Christiaans, I.
    van Langen, I. M.
    Birnie, E.
    Bonsel, G. J.
    Smets, E. M. A.
    Wilde, A. A. M.
    NETHERLANDS HEART JOURNAL, 2009, 17 (12) : 464 - 469
  • [36] Novel troponin T mutation in a family with dilated cardiomyopathy and sudden cardiac death; Implications for cardiomyopathy phenotypes
    Stefanelli, CB
    Rosenthal, A
    Ensing, GJ
    Russell, MW
    CIRCULATION, 2003, 108 (17) : 51 - 51
  • [37] Family History of Sudden Death Should Be a Primary Indication for Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy
    Maron, Martin S.
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (11) : 1402 - 1406
  • [38] A Family History of Sudden Death Should Not Be a Primary Indication for an Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy
    Watkinson, Oliver T.
    Elliott, Perry M.
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (11) : 1407 - 1409
  • [39] A novel mutation in the troponin I gene is associated with sudden cardiac death in familial hypertrophic cardiomyopathy.
    Klausen, IC
    Mogensen, J
    Egeblad, H
    Baandrup, U
    Borglum, AD
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A305 - A305
  • [40] Identification of a novel likely pathogenic TPM1 variant linked to hypertrophic cardiomyopathy in a family with sudden cardiac death
    Azimi, Amir
    Soveizi, Mahdieh
    Salmanipour, Alireza
    Mozafarybazargany, Mohammadhossein
    Jolfayi, Amir Ghaffari
    Maleki, Majid
    Kalayinia, Samira
    ESC HEART FAILURE, 2024, 11 (05): : 2481 - +